[go: up one dir, main page]

MX2020011581A - Catéter de globo. - Google Patents

Catéter de globo.

Info

Publication number
MX2020011581A
MX2020011581A MX2020011581A MX2020011581A MX2020011581A MX 2020011581 A MX2020011581 A MX 2020011581A MX 2020011581 A MX2020011581 A MX 2020011581A MX 2020011581 A MX2020011581 A MX 2020011581A MX 2020011581 A MX2020011581 A MX 2020011581A
Authority
MX
Mexico
Prior art keywords
ureter
chemotherapeutic
formulation
renal pelvis
balloon
Prior art date
Application number
MX2020011581A
Other languages
English (en)
Inventor
Michael G Oefelein
Original Assignee
Lipac Oncology Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipac Oncology Llc filed Critical Lipac Oncology Llc
Publication of MX2020011581A publication Critical patent/MX2020011581A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026—Multi-lumen catheters with stationary elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • A61M25/0075—Valve means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0082—Catheter tip comprising a tool
    • A61M25/0084—Catheter tip comprising a tool being one or more injection needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0097—Catheters; Hollow probes characterised by the hub
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1018—Balloon inflating or inflation-control devices
    • A61M25/10184—Means for controlling or monitoring inflation or deflation
    • A61M25/10185—Valves
    • A61M25/10186—One-way valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/005—Devices for introducing or retaining media, e.g. remedies, in cavities of the body for contrast media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • A61M25/0075—Valve means
    • A61M2025/0076—Unidirectional valves
    • A61M2025/0078—Unidirectional valves for fluid inflow from the body into the catheter lumen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/1056—Balloon catheters with special features or adapted for special applications having guide wire lumens outside the main shaft, i.e. the guide wire lumen is within or on the surface of the balloon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

El invento administra localmente un agente quimioterapéutico o de contraste radiográfico a un carcinoma urotelial del tracto superior (UTUC, por sus siglas en inglés). El invento incluye un catéter de globo con un canal de trabajo y un globo colocado dentro del uréter/pelvis renal a través de un acceso ureteral retrógrado o anterógrado. El globo se infla para que obstruya temporalmente el uréter, y se infusiona una formulación con un agente quimioterapéutico dentro del canal de trabajo del catéter y se permite que permanezca en el uréter/pelvis renal por un periodo suficiente para que la formulación se adhiera y penetre la pared urotelial. Las formulaciones pueden ser liposomales o no liposomales. Al menos una parte de la formulación de agente quimioterapéutico se adhiere a la pared urotelial mientras se instila y permanece en el uréter/pelvis renal. Los métodos del invento pueden ejecutarse como una terapia adyuvante para otros métodos para tratar UTUC, incluyendo la ablación o extirpación ureteroscópica del tumor.
MX2020011581A 2018-05-04 2019-05-06 Catéter de globo. MX2020011581A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862666848P 2018-05-04 2018-05-04
US201862680172P 2018-06-04 2018-06-04
PCT/US2019/030833 WO2019213648A1 (en) 2018-05-04 2019-05-06 Balloon catheter

Publications (1)

Publication Number Publication Date
MX2020011581A true MX2020011581A (es) 2021-01-29

Family

ID=68386946

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020011581A MX2020011581A (es) 2018-05-04 2019-05-06 Catéter de globo.

Country Status (9)

Country Link
US (1) US20210236769A1 (es)
EP (1) EP3796965A4 (es)
JP (1) JP2021523808A (es)
KR (1) KR20210005948A (es)
CN (1) CN112236188A (es)
CA (1) CA3138484A1 (es)
MX (1) MX2020011581A (es)
WO (1) WO2019213648A1 (es)
ZA (1) ZA202006968B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112354068A (zh) * 2020-11-12 2021-02-12 福建省立医院 一种肾盂压力监测球囊灌注导管
CN113058136A (zh) * 2021-03-29 2021-07-02 四川省肿瘤医院 一种上尿路上皮癌灌注用注液管、气囊、装置及使用方法
CN113598862B (zh) * 2021-07-16 2023-06-13 昆明医科大学第一附属医院 一种输尿管封堵器
CN114569868A (zh) * 2022-03-01 2022-06-03 中国人民解放军西部战区总医院 一种新型双层药物球囊

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0724056A (ja) * 1993-07-06 1995-01-27 Olympus Optical Co Ltd 生体内留置具
US6364868B1 (en) * 1995-08-02 2002-04-02 The Trustees Of Columbia University In The City Of New York Ureteral catheter and tissue expander and method of megaureter creation
ES2214704T3 (es) * 1997-04-07 2004-09-16 Cook Urological Inc. Cateter de drenaje con miembro de retencion de respaldo.
US6949125B2 (en) * 2002-04-16 2005-09-27 Boston Scientific Scimed, Inc. Ureteral stent with end-effector and related methods
US20090171241A1 (en) * 2006-03-03 2009-07-02 Garcia Maurice M System and method for urinary tract cell collection, diagnosis, and chemotherapy
WO2011053500A1 (en) * 2009-10-30 2011-05-05 Wilson-Cook Medical Inc. Balloon catheter with detachable hub, and methods for same
DK2635338T3 (da) * 2010-11-03 2019-01-02 Coloplast As Urologisk anordning
CN201969170U (zh) * 2011-01-05 2011-09-14 中国人民解放军第三军医大学第三附属医院 一种带有气囊的输尿管导管
CN202620447U (zh) * 2012-06-11 2012-12-26 陈雷振 一种用于经皮肾镜取石术的双腔气囊输尿管导管
US10092724B2 (en) * 2013-05-07 2018-10-09 Lamina Solutions Llc Retention drainage catheter
US20160175559A1 (en) * 2014-12-23 2016-06-23 Cook Medical Technologies Llc Medical Devices for Delivery and Retention of Bioactive Agents
EP3103500A1 (de) * 2015-06-11 2016-12-14 Lohmann & Rauscher GmbH Offenporiger ballonkatheter
MX2018008267A (es) * 2016-01-07 2018-09-28 Univ Western Health Sciences Formulaciones para el tratamiento del cancer de vejiga.
CN205948170U (zh) * 2016-05-18 2017-02-15 谭新玉 一种导尿管

Also Published As

Publication number Publication date
US20210236769A1 (en) 2021-08-05
EP3796965A4 (en) 2022-01-26
EP3796965A1 (en) 2021-03-31
KR20210005948A (ko) 2021-01-15
ZA202006968B (en) 2022-06-29
WO2019213648A1 (en) 2019-11-07
JP2021523808A (ja) 2021-09-09
CA3138484A1 (en) 2019-11-07
CN112236188A (zh) 2021-01-15

Similar Documents

Publication Publication Date Title
MX2020011581A (es) Catéter de globo.
CA2874661C (en) Control catheters and methods for pulmonary suffusion and related therapies
BR112016028550A2 (pt) guia e introdutor do cateter com agulha sub-retinal tangencial
AU2023241285B2 (en) Multi-lumen indwelling catheter
WO2007135431A3 (en) Vessel sealing device and methods
WO2007117915A8 (en) Closed loop catheter photopolymerization system for treating a vascular condition
JP2016534787A5 (es)
WO2019051274A3 (en) DEVICES FOR THE TREATMENT OF BRONCHOPULMONARY TUMORS
WO2012156914A3 (en) Microporous balloon catheter, delivery system, and methods of manufacture and use
BR112018003616A2 (pt) método de entrega de líquidos para sistema de rf resfriado
NZ753214A (en) Methods of treating upper tract urothelial carcinomas
Yamamoto et al. Percutaneous direct-endoscopic necrosectomy for walled-off pancreatic necrosis
Schwerfeld-Bohr et al. Prospective randomized multicenter study comparing limited vs extended pelvic lymphadenectomy in intermediate and high risk prostate cancer-comparison of complications (SEAL, AUO AP 55/09)
Shin et al. Intraductal thermal injury using a heat probe and radiofrequency ablation electrode in a swine model of biliary stenosis
US10335573B2 (en) Intraperitoneal chemotherapy medical devices, kits, and methods
Björk The use of the Seldinger technic for percutaneous introduction of drainage tubes into thoracic cavities
RU2330621C1 (ru) Способ снижения токсических эффектов химиопрепаратов во время изолированной перфузии печени
Koh et al. Massive subcapsular air collection in the liver: A rare life-threatening complication following ERCP rendezvous procedure.
Lee et al. Endoscopic Management of Early and Advanced Hepatic Tumors
Maheshwari et al. Randomized and prospective trial comparing tract creation using plasma vaporization with balloon dilatation in percutaneous nephrolithotomy
Ohlmann et al. Comment re: Sternberg CN, Skoneczna I, Kerst JM, et al. Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial. Lancet Oncol 2015; 16: 76-86
Ashkar et al. An Unusual Presentation of Metastatic Hypopharyngeal Squamous Cell Carcinoma: 1512
Kim et al. Synchronous Presentation of Three Distinct Pancreaticobiliary Tumors: Pancreatic Ductal Adenocarcinoma, Cholangiocarcinoma, and a Pancreatic Neuroendocrine Tumor: 1452
Ashkar et al. Obstructed Common Bile Duct Stent Leading to a Spontaneous Choledocho-duodenal Fistula: A Rare Complication: 1513
Sathyamurthy et al. Endoscopic Tattooing Site Presenting as Colonic Pseudotumor: 1511